Our therapeutic platform is being developed for treatments where low-resolution neuromodulation therapies have failed and become therapies of last resort in chronic pain management and sensory-motor paralysis.
Our therapy measures the stimulation dosage to confirm treatment and algorithms uniquely adapts stimulation to personalize the therapy for each person.